Navigation Links
Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
Date:9/22/2010

WALTHAM, Mass., Sept. 22 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present at the Sachs Biotech in Europe Investor Forum Wednesday, September 29, 2010 at the Radisson Blu hotel in Zurich, Switzerland.

Dr. Horobin will be a panelist on the Oncology Investment Panel at 12:00 pm CEST.  Her presentation will be given at 5:00 p.m. CEST and will include an overview of upcoming milestones including the ongoing phase 2 clinical program for entinostat in breast, lung, colorectal cancer and hematologic malignancies.

The presentation will be available at Syndax's website, www.syndax.com.

About SyndaxSyndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused pharmaceutical company. Syndax is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens. Formed in 2005, the company's intellectual property is based on work from scientific founder Ronald Evans, Ph.D., recipient of the 2004 Albert Lasker Prize for Basic Medical Research, a Member of the National Academy of Sciences, a professor at the Salk Institute for Biological Studies and a Howard Hughes Medical Institute Investigator.

Syndax holds rights to entinostat from Bayer Schering Pharma and is backed by top-tier Venture Capital firms: Domain Associates, MPM Capital, Avalon, Pappas and Forward Ventures.  For more information please visit www.syndax.com.Contact InformationJoanna Horobin, M.D.

Danielle Bertrand Syndax Pharmaceuticals, Inc.

WCG Tel: 781-419-1402

Tel: 415-946-1056 jhorobin@syndax.com

dbertrand@wcgworl
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
3. Access Pharmaceuticals, Inc. Signs $30M MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
4. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
5. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
6. NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
7. Lead Plaintiffs Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is Tip of the Iceberg of Future Off-Label Marketing Lawsuits
8. Cempra Pharmaceuticals to Present at the UBS Global Life Sciences Conference
9. HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
10. Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
11. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... , June 17, 2013  Hanger, Inc. (NYSE: ... credit agreement that increases its senior secured facilities to ... million previously.  The new credit agreement includes a $200 ... loan facility.  The previous credit agreement was comprised of ... million term loan.  Each new facility matures on June ...
(Date:6/17/2013)... 2013 BioMed Realty Trust, Inc. (NYSE: ... declared a second quarter 2013 dividend of $0.235 per share ... dividend of $0.94 per common share. The ... stockholders of record at the close of business on June ... BioMed Realty delivers optimal real estate solutions for biotechnology ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3
(Date:6/18/2013)... June 18, 2013 Parker Waichman ... the rights of victims injured by defective medical devices, ... of Medtronic’s Infuse bone graft products are now available. ... medical journal, the two studies serve up two key ... when comparing Infuse and the traditional bone graft; and ...
(Date:6/18/2013)... June 18, 2013 Sun Buick GMC, Moosic, ... Health Services 20th Annual Golf Tournament on Thursday, June 20, ... hole-in-one prize is a 2013 Buick Verano and will go ... a hole-in-one on Irem’s 7th hole. , The MFHS golf ... is a four person captain and crew team for 18 ...
(Date:6/18/2013)... developed at Case Western Reserve University,s College of ... has made available avatarsvirtual patientsto train speech-language pathologists. ... training to evaluate speech-language disorders to practice using ... trainee, because a diagnosis doesn,t have to be ... students studying to become speech-language pathologists have previously ...
(Date:6/18/2013)... myCNAjobs announces the addition of new resources to ... to the Caregiver Resources Center. , As more caregivers ... baby boomers each day, the need for caregiver ... has never been greater. myCNAjobs, the fastest growing ... the first-ever free resource center for caregivers seeking professional ...
(Date:6/18/2013)... New York, New York (PRWEB) June 18, 2013 ... forward in both state and federal court, a new report ... of more than 70,000 U.S. Food & Drug Administration (FDA) ... According to NewsChannel5 in Cleveland, Ohio, over 4.700 Mirena ... since 2008, while more than 1,300 have reportedly experienced uterine ...
Breaking Medicine News(10 mins):Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:SimuCase avatars advance speech-language pathology training 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3
... manipulation of inheritable genes to enable people to produce ... family relationships and on being human, warns a leading ... diseases hold out great hope for IGM technology, which ... as Huntington’s Disease and schizophrenia on to their children.// ...
... the risk of pancreatic cancer in both sexes,while moderate ... obese individuals,says Dr. Dominique S. Michaud the head ... National Cancer Institute in Rockville, Maryland and colleagues collected ... 75 years of age, who participated in the Health ...
... itself by growing new cells after a heart attack. This surprising ... Piero Anversa and colleagues of the New York Medical College in ... divide after a heart attack.// , ... died within a few days of having a heart attack and ...
... According to researchers, patients suffering from Angina may have ... doses of antibiotics. Angina, a common cardiovascular disorder affecting ... chest pain caused by blood vessels too clogged to ... Current treatment involves either medication or for more serious ...
... week could significantly increase the success rate of pig-to-human ... indicated that rejection of animal cells and organs by ... presence of the gene alpha 1,3 galactosyl transferase. The ... to the surface of pig cells, flagging them up ...
... technique to keeping heart arteries flowing easily after angioplasty ... major weakness of the common procedure.Doctors released the ... drug-coated stent. In testing on 30 patients over three ... an accomplishment almost unheard of in medicine.// ,More ...
Cached Medicine News:Health News:Perfect babies boon or a bane? 2Health News:Antibiotic, Gene Therapy Help Treat Angina 2Health News:Antibiotic, Gene Therapy Help Treat Angina 3Health News:Xenotransplantation “breakthrough” 2Health News:A ray of hope in Angioplasty dilemma 2
... The ACS:180 SE is ... ACS:180 PLUS, consisting of important ... further simplify routine operation and ... represents the "Next Generation" ACS:180. ...
... Chrono-log's wide range of Platelet aggregometers ... to meet particular needs. Single, dual ... with chart recorder outputs or digital ... Chrono-log Optical aggregometers, which measure platelet ...
... Platelet aggregometers allows to choose the ... Single, dual and four sample units ... or digital computer outputs. In addition ... measure platelet aggregation in platelet-rich-plasma (PRP), ...
... The PAP-4 is a four channel Platelet ... available: von willebrand assay (Ristocetin cofactor), platelet ... also be used for the evaluation and ... channels allow four tests to be run ...
Medicine Products: